254 related articles for article (PubMed ID: 34992243)
1. What pharmacological interventions are effective in binge-eating disorder? Insights from a critical evaluation of the evidence from clinical trials.
Heal DJ; Gosden J
Int J Obes (Lond); 2022 Apr; 46(4):677-695. PubMed ID: 34992243
[TBL] [Abstract][Full Text] [Related]
2. Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology.
Heal DJ; Smith SL
J Psychopharmacol; 2022 Jun; 36(6):680-703. PubMed ID: 34318734
[TBL] [Abstract][Full Text] [Related]
3. Treatment of binge eating disorder.
Wilson GT
Psychiatr Clin North Am; 2011 Dec; 34(4):773-83. PubMed ID: 22098803
[TBL] [Abstract][Full Text] [Related]
4. Orlistat with behavioral weight loss for obesity with versus without binge eating disorder: randomized placebo-controlled trial at a community mental health center serving educationally and economically disadvantaged Latino/as.
Grilo CM; White MA
Behav Res Ther; 2013 Mar; 51(3):167-75. PubMed ID: 23376451
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological treatment of binge eating disorder: update review and synthesis.
Reas DL; Grilo CM
Expert Opin Pharmacother; 2015; 16(10):1463-78. PubMed ID: 26044518
[TBL] [Abstract][Full Text] [Related]
6. Naltrexone + Bupropion Combination for the Treatment of Binge-eating Disorder with Obesity: A Randomized, Controlled Pilot Study.
Grilo CM; Lydecker JA; Morgan PT; Gueorguieva R
Clin Ther; 2021 Jan; 43(1):112-122.e1. PubMed ID: 33218742
[TBL] [Abstract][Full Text] [Related]
7. Combining Pharmacological and Psychological Treatments for Binge Eating Disorder: Current Status, Limitations, and Future Directions.
Grilo CM; Reas DL; Mitchell JE
Curr Psychiatry Rep; 2016 Jun; 18(6):55. PubMed ID: 27086316
[TBL] [Abstract][Full Text] [Related]
8. Predicting meaningful outcomes to medication and self-help treatments for binge-eating disorder in primary care: The significance of early rapid response.
Grilo CM; White MA; Masheb RM; Gueorguieva R
J Consult Clin Psychol; 2015 Apr; 83(2):387-94. PubMed ID: 25622201
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapeutic strategies for treating binge eating disorder. Evidence from clinical trials and implications for clinical practice.
Amodeo G; Cuomo A; Bolognesi S; Goracci A; Trusso MA; Piccinni A; Neal SM; Baldini I; Federico E; Taddeucci C; Fagiolini A
Expert Opin Pharmacother; 2019 Apr; 20(6):679-690. PubMed ID: 30696303
[TBL] [Abstract][Full Text] [Related]
10. An open-label trial on the efficacy and tolerability of naltrexone/bupropion SR for treating altered eating behaviours and weight loss in binge eating disorder.
Carbone EA; Caroleo M; Rania M; Calabrò G; Staltari FA; de Filippis R; Aloi M; Condoleo F; Arturi F; Segura-Garcia C
Eat Weight Disord; 2021 Apr; 26(3):779-788. PubMed ID: 32356145
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy of binge-eating disorder: a review.
Goracci A; di Volo S; Casamassima F; Bolognesi S; Benbow J; Fagiolini A
J Addict Med; 2015; 9(1):1-19. PubMed ID: 25629881
[TBL] [Abstract][Full Text] [Related]
12. Lisdexamfetamine for binge eating disorder in adults: a systematic review of the efficacy and safety profile for this newly approved indication - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Citrome L
Int J Clin Pract; 2015 Apr; 69(4):410-21. PubMed ID: 25752762
[TBL] [Abstract][Full Text] [Related]
13. Impulsivity-focused group intervention to reduce binge eating episodes in patients with binge eating disorder: study protocol of the randomised controlled IMPULS trial.
Schag K; Leehr EJ; Martus P; Bethge W; Becker S; Zipfel S; Giel KE
BMJ Open; 2015 Dec; 5(12):e009445. PubMed ID: 26685032
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of the efficacy of psychological and medical treatments for binge-eating disorder.
Hilbert A; Petroff D; Herpertz S; Pietrowsky R; Tuschen-Caffier B; Vocks S; Schmidt R
J Consult Clin Psychol; 2019 Jan; 87(1):91-105. PubMed ID: 30570304
[TBL] [Abstract][Full Text] [Related]
15. Binge eating disorder revisited: what's new, what's different, what's next.
Citrome L
CNS Spectr; 2019 Aug; 24(S1):4-13. PubMed ID: 31196238
[TBL] [Abstract][Full Text] [Related]
16. An Innovative Disease-Drug-Trial Framework to Guide Binge Eating Disorder Drug Development: A Case Study for Topiramate.
Kalaria SN; McElroy SL; Gobburu J; Gopalakrishnan M
Clin Transl Sci; 2020 Jan; 13(1):88-97. PubMed ID: 31386273
[TBL] [Abstract][Full Text] [Related]
17. Lisdexamfetamine and binge-eating disorder: A systematic review and meta-analysis of the preclinical and clinical data with a focus on mechanism of drug action in treating the disorder.
Schneider E; Higgs S; Dourish CT
Eur Neuropsychopharmacol; 2021 Dec; 53():49-78. PubMed ID: 34461386
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological approaches to the management of binge eating disorder.
Brownley KA; Peat CM; La Via M; Bulik CM
Drugs; 2015 Jan; 75(1):9-32. PubMed ID: 25428709
[TBL] [Abstract][Full Text] [Related]
19. Current and emerging drug treatments for binge eating disorder.
Reas DL; Grilo CM
Expert Opin Emerg Drugs; 2014 Mar; 19(1):99-142. PubMed ID: 24460483
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological approaches in the treatment of binge eating disorder.
Appolinario JC; McElroy SL
Curr Drug Targets; 2004 Apr; 5(3):301-7. PubMed ID: 15058314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
